Annemarie Ward
CEO @FAVORUK advocating for those suffering & recovering from #Addiction. #DrugDeaths #ScotlandsShame. Interested in Justice, Mercy & Good Faith ✝️ #UTalkWeDie
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 163 | Founded | 2 years ago | Last Issue | 9 days ago |
| Active | |||||
Read this Newsletter
annemarieward.substack.comLatest Issues
The Politics of Unintended Consequences
What Belgium’s cannabis crisis tells us about the oldest mistake in politics ?
Justin Trudeau promised that legalising cannabis would keep the drug away from children and take profits away from organised crime. Eight years later, Belgian...
Remembering Recovery
The previous essay argued that recovery is not fundamentally a theory of addiction. It is a theory of the human person. It asks not simply how people stop using drugs or alcohol, but how they become someone new. It insists that human beings...
Becoming Someone New
The Question Left by SIFT
In the first essay, I argued that Scotland’s own evidence increasingly pointed beyond clinical interventions towards something less tangible but ultimately more powerful: recovery capital. The Scottish Health S...
When Compassion Forgot Its Purpose
If Scotland wasn’t asking the right questions, how did that happen?
It certainly wasn’t because people stopped caring.
Scotland’s addiction system has never been indifferent. That is one of the reasons criticism of it can become so uncomf...
Beyond the Body Count
I have written this as one sustained essay in four acts, almost like Hitchens’ The Missionary Position or Roger Scruton’s longer essays. Each part can stand alone for readers arriving midway through the series, but together they amount to a...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Annemarie Ward.
| Subscribers | Engagement | 75 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #227 | |
| #174 |
Authors
The writers behind this newsletter.
CEO @FAVORUK advocating for those suffering & recovering from #Addiction. #DrugDeaths #ScotlandsShame. Interested in Justice, Mercy & Good Faith ✝️ #UTalkWeDie
Frequently Asked Questions
How can I access the email archive for Annemarie Ward?
You can find recent issues that have been published by Annemarie Ward on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Annemarie Ward have?
To see how many people subscribe to Annemarie Ward, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Annemarie Ward?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Annemarie Ward as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Annemarie Ward?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Annemarie Ward using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Annemarie Ward?
Scroll up to where it says Related Newsletters to see other publications like Annemarie Ward. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Annemarie Ward?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.